Item 9 Labs Corp (OTCMKTS:INLB) Stock Continues to See Buying Pressure: Here is Why
Item 9 Labs Corp (OTCMKTS:INLB) stock continued to trend higher on Wednesday as the stock has soared 11% over the past week.
Market Action
In the previous trading session, INLB stock gained 2.50% to $1.67. A total of 10k shares traded for the session hands, compared to its average volume of 18k shares. The stock opened at $1.63 and moved in a range of $1.5900 – 1.6900.
Key Trigger
Item 9 Labs Corp. to Present at A.G.P.’s Virtual Fall Consumer Cannabis Conference October 5
Item 9 Labs Corp announced it will participate in the A.G.P. Virtual Fall Consumer Cannabis Conference on Tuesday, October 5, 2021.
The conference features up to 30 select companies in the cannabis industry and will be attended by approximately 200 qualified institutional investment funds from around the world.
The Company’s Chief Executive Officer Andrew Bowden, Chief Strategy Officer Jeffrey Rassas, and Chief Franchise Officer Mike Weinberger will be conducting one-on-one meetings with buy and sell-side analysts as well as qualified accredited investors to discuss:
Limited meeting times are available between 11 a.m. to 2:30 p.m. ET. For more information or to schedule a meeting with Item 9 Labs Corp. contact agpevents@allianceg.com or an A.G.P representative.
Trader Notes:
From the technical point of view, INLB stock looks bearish with the stock trading below its 50-day and 200-Day SMA stand at $2.5 and $2.91 respectively. RSI stood at 43 – signals neutral trend.
